Cardiac Transplantation following Cobalt Cardiomyopathy from Bilateral Metal-on-Metal Hip Replacements.
Peter SzedlakAmrik VirdiPaul CacciottoloStephen ShepherdStephen PettitFlorian FalterPublished in: Case reports in anesthesiology (2022)
A fifty-two-year-old man underwent heart transplantation at our centre after four years of developing progressive heart failure symptoms due to cobalt toxicity-related cardiomyopathy. Between the ages of forty and forty-two, he underwent bilateral metal-on-metal hip arthroplasties for early onset osteoarthritis. Six years later, he developed increasing fatigue and pericardial effusions. Following a prolonged period of deterioration without a clear cause, the diagnosis of cobalt toxicity-related cardiomyopathy due to cobalt-chromium alloy hip prostheses was eventually made. He underwent bilateral revision hip arthroplasties and was listed for heart transplantation. Metal-on-metal joint replacement is a rare cause of iatrogenic cobalt toxicity. Anaesthetists may encounter patients with unexplained symptoms of heart failure, having a high index of suspicion presenting an opportunity for early diagnosis and intervention before end-stage disease develops.
Keyphrases
- heart failure
- early onset
- total hip arthroplasty
- reduced graphene oxide
- left ventricular
- oxidative stress
- case report
- randomized controlled trial
- metal organic framework
- carbon nanotubes
- late onset
- rheumatoid arthritis
- multiple sclerosis
- stem cells
- atrial fibrillation
- acute heart failure
- knee osteoarthritis
- cardiac resynchronization therapy